Artificial intelligence-guided design of lipid nanoparticles for mRNA delivery
Acta Pharmaceutica Sinica B · 2026-02 · 16 (2) · 709-727
DOI: 10.1016/j.apsb.2025.11.029 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-02. Verfasst von Kexin Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang University, Zhejiang Province Natural Science Foundation.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) hold significant potential for mRNA-based therapeutics, as evidenced by their successful use in SARS-CoV-2 mRNA vaccines. LNPs effectively protect and transport mRNA to target sites, thereby ensuring its stability and efficient transfection. Despite the progress, some challenges remain in the development of mRNA-LNP delivery systems, such as limited targeting specificity, the complexity of formulations, and the time-consuming and high-throughput screening process. Artificial intelligence (AI) has emerged as a powerful tool to address these challenges, accelerating the design and optimization process of LNPs. AI-guided approaches can improve the efficiency of lipid structure and formulation screening by rapidly identifying key design parameters and employing predictive modeling to optimize LNP properties. The combination of AI and LNP technology offers significant advantages, including enabling the design of more personalized and precise delivery systems, streamlining the development process, and reducing the cost. This review discusses recent advancements in AI-guided mRNA-LNP delivery systems and highlights their potential to revolutionize mRNA therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.
- Research Center for Clinical Pharmacy, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- Liangzhu Laboratory, Zhejiang University, Hangzhou 311121, China.
- Eye Center of the Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310009, China.
- Zhejiang Key Laboratory of Pain Perception and Neuromodulation, Hangzhou 310009, China.
Förderung
- National Natural Science Foundation of China
- Zhejiang University
- Zhejiang Province Natural Science Foundation
Zitieren
APA
Su, K., Qiu, J., Xu, T., & Liu, S. (2026). Artificial intelligence-guided design of lipid nanoparticles for mRNA delivery. Acta Pharmaceutica Sinica B, 16(2), 709-727. https://doi.org/10.1016/j.apsb.2025.11.029
Vancouver
Su K, Qiu J, Xu T, Liu S. Artificial intelligence-guided design of lipid nanoparticles for mRNA delivery. Acta Pharmaceutica Sinica B. 2026;16(2):709-727. doi:10.1016/j.apsb.2025.11.029
BibTeX
@article{Su2026,
author = {Su, Kexin and Qiu, Junjie and Xu, Tengfei and Liu, Shuai},
title = {Artificial intelligence-guided design of lipid nanoparticles for mRNA delivery},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {2},
pages = {709--727},
doi = {10.1016/j.apsb.2025.11.029}
}
EUVIMED